Anthony D. Ormerod

Aberdeen, SCT, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 53 publications

Predicting the outcome of psoriasis treatment.

Predicting the outcome of psoriasis treatment.

Journal: The British journal of dermatology

Published: July 22, 2022

TGFβ2 Induces the Soluble Isoform of CTLA-4 - Implications for CTLA-4 Based Checkpoint Inhibitor Antibodies in Malignant Melanoma.

TGFβ2 Induces the Soluble Isoform of CTLA-4 - Implications for CTLA-4 Based Checkpoint Inhibitor Antibodies in Malignant Melanoma.

Journal: Frontiers in immunology

Published: August 24, 2021

Epidemiology, comorbidities and mortality of pyoderma gangrenosum: new insights.

Epidemiology, comorbidities and mortality of pyoderma gangrenosum: new insights.

Journal: The British journal of dermatology

Published: August 09, 2021

Characteristics and skin cancer risk of psoriasis patients with a history of skin cancer in BADBIR.

Characteristics and skin cancer risk of psoriasis patients with a history of skin cancer in BADBIR.

Journal: Journal of the European Academy of Dermatology and Venereology : JEADV

Published: January 31, 2021

Risks of basal cell and squamous cell carcinoma in psoriasis patients after treatment with biologic vs non-biologic systemic therapies.

Risks of basal cell and squamous cell carcinoma in psoriasis patients after treatment with biologic vs non-biologic systemic therapies.

Journal: Journal of the European Academy of Dermatology and Venereology : JEADV

Published: January 31, 2021

Low-Dose Vitamin D3 Supplementation Does Not Affect Natural Regulatory T Cell Population but Attenuates Seasonal Changes in T Cell-Produced IFN-γ: Results From the D-SIRe2 Randomized Controlled Trial.

Low-Dose Vitamin D3 Supplementation Does Not Affect Natural Regulatory T Cell Population but Attenuates Seasonal Changes in T Cell-Produced IFN-γ: Results From the D-SIRe2 Randomized Controlled Trial.

Journal: Frontiers in immunology

Published: October 29, 2020

Spoiled for choice? Are you confused by the number of biological options for psoriasis?

Spoiled for choice? Are you confused by the number of biological options for psoriasis?

Journal: The British journal of dermatology

Published: July 01, 2020

Dutch guidelines for psoriasis treatment.

Dutch guidelines for psoriasis treatment.

Journal: The British journal of dermatology

Published: January 04, 2019

New validated diagnostic criteria for pyoderma gangrenosum.

New validated diagnostic criteria for pyoderma gangrenosum.

Journal: Journal of the American Academy of Dermatology

Published: August 22, 2018

Infliximab is associated with an increased risk of serious infection in patients with psoriasis in the U.K. and Republic of Ireland: results from the British Association of Dermatologists Biologic Interventions Register (BADBIR).

Infliximab is associated with an increased risk of serious infection in patients with psoriasis in the U.K. and Republic of Ireland: results from the British Association of Dermatologists Biologic Interventions Register (BADBIR).

Journal: The British journal of dermatology

Published: June 13, 2018

Cumulative exposure to biological therapy and risk of cancer in patients with psoriasis: a meta-analysis of Psonet studies from Israel, Italy, Spain, the U.K. and Republic of Ireland.

Cumulative exposure to biological therapy and risk of cancer in patients with psoriasis: a meta-analysis of Psonet studies from Israel, Italy, Spain, the U.K. and Republic of Ireland.

Journal: The British journal of dermatology

Published: April 23, 2018

Diagnostic Criteria of Ulcerative Pyoderma Gangrenosum: A Delphi Consensus of International Experts.

Diagnostic Criteria of Ulcerative Pyoderma Gangrenosum: A Delphi Consensus of International Experts.

Journal: JAMA dermatology

Published: February 17, 2018

Showing 1-12 of 53

Last Updated: 09/26/2026